Cristobal Almendros Romero (Business Unit Manager Genetic QC), Gal.La Garcia Codina (Technical Liaison Associate) and Mirian Daniela Obrador (Technical Support Specialist) are in Barcelona between 29 & 31 October to speak to you at the World Vaccine Congress.
By providing detailed insights into the genetic makeup of pathogens, our NGS solutions allow scientists to identify and understand the mutations and variations that can affect vaccine efficacy. This technology enables the rapid sequencing of viral genomes, which is crucial for tracking the evolution of viruses and identifying new strains that may require updated vaccines.
By analyzing the genetic information of pathogens, researchers can pinpoint specific antigens that are most likely to produce a strong and lasting immune response. This targeted approach not only enhances the effectiveness of vaccines but also accelerates their development.
We use our expertise to help you develop and test the best possible vaccine solutions. Feel free to discuss your current problems and complications and we aim to assist you!
Not sure if our genomics and proteomics solutions are fitting for you? Come have a chat at our booth and let’s connect!
About World Vaccine Congress
The World Vaccine Congress is an award-winning series of conferences that have grown to become the largest and most established vaccine meetings across the globe.
Following a record attendance in 2023 of 2000+ attendees, the World Vaccine Congress Europe will be back, bringing together the most senior and informed industry experts across the entire vaccine landscape. Covering vaccine progress in: Infectious Diseases, Cancer Immunotherapy, One Health and Veterinary Vaccines, Clinical Development, Manufacture, Safety, Supply, Access, Emerging Infectious
From basic research to commercial manufacture, this one meeting covers the whole vaccine value chain where science, government and manufacturers all come together to create ground- breaking progress.
